Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

Licensing agreements for innovator GLP1R drugs weigh in with over $6.2bn in 2024 – Pharmaceutical Technology

Innovator drugs targeting glucagon-like peptide-1 receptor (GLP1R) witnessed a 595% increase in total licensing agreement deal value from 2019 to 2024 year-to-date (YTD), with more

August 21, 2024

China’s NMPA accepts NDA for AnHeart lung cancer therapy

Share this article Taletrectinib is intended to treat adult patients with locally advanced or metastatic ROS1-positive NSCLC. Credit: Stokkete / Shutterstock.com. China’s National Medical Products

November 23, 2023

U.S. News Releases This Year’s ‘Best Medical Schools,’ With Changes

After being delayed for the second year in a row, U.S. News & World Report rolled out this year’s “Best Medical Schools” rankings with substantial

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.